Did some calcs and some reading. Feel free to add or correct.
So... Vince sold Anacor to Pfizer for 5.2 billion $USD in Jun 2016, which was for an eczema gel that reached phase 3.
Taking a USD inflation calculator, this is 6.82 billion $USD in today's value.
If Vince meets this previous achievement (not even beat it right), noting we got 1.81 billion shares on issue, this is a SP of $3.77 USD or $5.61 AUD for BOT.
We don't have a phase 3 drug; we got better. We got an FDA approved drug. Imagine what that means for BOT's future.
Did some calcs and some reading. Feel free to add or...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.015(4.05%) |
Mkt cap ! $699.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.0¢ | $1.537M | 4.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 91664 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |